NewslettersCancer Stem Cell NewsPulmonary Cell NewsDepleting DDX1 Sensitizes Non-Small Cell Lung Cancer Cells to Chemotherapy by Attenuating Cancer Stem Cell TraitsBy Bob - March 22, 20230321The authors found that depleting DEAD-box helicase 1 (DDX1) increased the sensitivity of non-small cell lung cancer cells to the chemotherapy drug cisplatin, increased cell apoptosis, and inhibited cell migration and invasion.[Life Sciences]Abstract